High Tower Advisors, LLC Vbi Vaccines Inc Transaction History

High Tower Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.38 - $22.5 $7,296 - $432,000	-19,200 Reduced 22.87%	64,737 $25,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $23.4 $1 - $46	2 Added 0.0%	83,937 $58,000
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $977 - $1,901	-770 Reduced 0.91%	83,935 $139,000
Q4 2021 Feb 10, 2022	BUY	$2.21 - $3.22 $85,118 - $124,018	38,515 Added 83.38%	84,705 $196,000
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $574 - $762	205 Added 0.45%	46,190 $143,000
Q2 2021 Aug 06, 2021	BUY	$2.61 - $4.17 $12,593 - $20,120	4,825 Added 11.72%	45,985 $156,000
Q1 2021 May 10, 2021	BUY	$2.91 - $4.32 $119,775 - $177,811	41,160 New	41,160 $127,000
Q4 2020 Feb 10, 2021	SELL	$2.15 - $3.5 $90,063 - $146,615	-41,890 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.77 - $6.17 $29,445 - $65,587	-10,630 Reduced 20.24%	41,890 $119,000
Q2 2020 Aug 10, 2020	BUY	$0.87 - $3.13 $35,652 - $128,267	40,980 Added 355.11%	52,520 $164,000
Q1 2020 May 21, 2020	SELL	$0.73 - $1.91 $919 - $2,406	-1,260 Reduced 9.84%	11,540 $11,000
Q4 2019 Feb 14, 2020	BUY	$0.48 - $1.38 $720 - $2,070	1,500 Added 13.27%	12,800 $17,000
Q3 2019 Nov 12, 2019	BUY	$0.47 - $1.05 $5,311 - $11,865	11,300 New	11,300 $5,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.